Arrowhead Pharmaceuticals (ARWR) Revenue Growth (3y) (2013 - 2026)
Arrowhead Pharmaceuticals (ARWR) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 12.39 Bn | 10.60 Bn | - | -20.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.41% |
| Dec 31, 2025 | 61.62% |
| Sep 30, 2025 | 101.02% |
| Jun 30, 2025 | -5.03% |
| Mar 31, 2025 | 52.91% |
| Dec 31, 2024 | -55.00% |
| Dec 31, 2023 | -44.97% |
| Sep 30, 2023 | 28.24% |
| Jun 30, 2023 | -16.70% |
| Mar 31, 2023 | 83.87% |
| Dec 31, 2022 | 28.53% |
| Sep 30, 2022 | -9.99% |
| Jun 30, 2022 | -36.32% |
| Mar 31, 2022 | 22.39% |
| Dec 31, 2021 | -7.49% |
| Sep 30, 2021 | 50.39% |
| Jun 30, 2021 | 298.10% |
| Mar 31, 2021 | 269.55% |
| Dec 31, 2020 | 82.41% |
| Sep 30, 2020 | -4.32% |